AstraZeneca, Ionis report major trial failure with heart disease drug
Andrew covers the biopharma industry, scientific research, and public health across the continent. You can reach Andrew confidentially…
Philips agrees to acquire SpectraWAVE Inc.
Sources [1] The SpectraWAVE HyperVue Imaging System and the Starlight Imaging Catheter is a US Class 2…
Stanford Medicine study shows why mRNA-based COVID-19 vaccines can cause myocarditis
“Two proteins, named CXCL10 and IFN-gamma, popped up. We think these two are the major drivers of myocarditis,”…
A disproportionality analysis of real-world adverse events associated with tirofiban from the FAERS database
Tirofiban, as a GP IIb/IIIa receptor antagonist, competitively inhibits the bridging of platelets via fibrin, which is the…
Philips FHI 2025 Cardiology Snapshot
Royal Philips (NYSE: PHG, AEX: PHIA) is a leading health technology company focused on improving people’s health and…
Association between C-reactive protein-triglyceride glucose index and Future cardiovascular disease risk in a population with cardiovascular-Kidney-metabolic syndrome stage 0–3
This study is the first to investigate the relationship between the CTI and CVD risk among individuals with…
Phase 3 Trial Confirms Sarilumab Improves Polymyalgia Rheumatica Outcomes
Vibeke Strand, MD Credit: PRIME Education New phase 3 data supported the effectiveness of sarilumab 200 mg every…